Novel Meibomian Gland and Tarsal Conjunctival Changes Associated with Trastuzumab, Pertuzumab, and Anastrozole Treatment for Metastatic HER2 Positive Breast Cancer: A Case Report and Literature Review

The aim of the study was to report a case of severe meibomian gland dysfunction (MGD) and conjunctival changes associated with trastuzumab, pertuzumab, and anastrozole therapy in a HER-2 positive breast cancer patient. A 57-year-old white woman was treated with trastuzumab and pertuzumab biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcsay-Veres, Amarilla, Tokes, Anna Maria, Toth, Jeannette, Szilagyi, Zsuzsa, Toth, Eva Katalin, Nagy, Zoltan Z., Horvath, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149449/
https://www.ncbi.nlm.nih.gov/pubmed/35702674
http://dx.doi.org/10.1159/000524176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149449/
https://www.ncbi.nlm.nih.gov/pubmed/35702674
http://dx.doi.org/10.1159/000524176

Ejemplares similares